Space Shuttle Atlantis’s three Block II RS-25D main engines at liftoff during the launch of STS-110. This image was extracted from engineering motion picture footage taken by a tracking camera.
The retired-Space Shuttle program (like its predecessor Apollo) ushered much innovation to the public. And, if one were to ‘google’ the terms, nasa spinoff database –one may get lucky enough to see a lot of which many take for granted. The database is chock full with the ‘fruits of our labor;’ we truly hit the proverbial jackpot by going into space. For instance, I draw attention to the utilization of ‘photochemistry;’ to those of us who are not familiar with the terminology I give a quick definition:
Photochemistry is utilizing light (e.g. the Sun) to generate a desired (or needed) outcome. Sounds simple enough. . . .
When we do trek beyond our solar system, it may be necessary to grow foodstuffs. Sunlight has guided our days and helped to fill our nights with dreams. So, in the quest to grow foodstuffs, we are learning to utilize artificial light sources aboard the shuttle and the ISS. The ‘spinoff’ of utilizing light stands to benefit us in many novel ways—
From the NASA technologies website:
Red light-emitting diodes are growing plants in space and healing humans on Earth. The LED technology used in NASA space shuttle plant growth experiments has contributed to the development of medical devices such as award-winning WARP 10, a hand-held, high-intensity, LED unit developed by Quantum Devices Inc. The WARP 10 is intended for the temporary relief of minor muscle and joint pain, arthritis, stiffness, and muscle spasms, and also promotes muscle relaxation and increases local blood circulation. The WARP 10 is being used by the U.S. Department of Defense and U.S. Navy as a noninvasive “soldier self-care” device that aids front-line forces with first aid for minor injuries and pain, thereby improving endurance in combat. The next-generation WARP 75 has been used to relieve pain in bone marrow transplant patients, and will be used to combat the symptoms of bone atrophy, multiple sclerosis, diabetic complications, Parkinson’s disease, and in a variety of ocular applications. (Spinoff 2005, 2008)
A major innovation (IMO), however, is the ‘direct’ utilization of light in cancer chemotherapy. A few years back, scientists recognized that certain drugs are active only when shined upon by light—so in other words, if one were to give a cancer patient a drug—it would act against the cancer cells when ‘shined upon.’ Thus, the targeting of cancer cells (in certain cases) became more efficient. (see the cited Nature article at the end of the post)
Most of us utilize space age technology and conjure our own versions of the technology, as well. For instance when one looks at instances of invention, one notices a cluttered path (at times). It is at those times we gain a sense of personal innovation and possibly inspiration. What could be more inspiring than to gain a mastery over the natural world? Science and engineering journals display articles of genius, innovation and refined curiosity.
Often it is not that one has a good idea—we may stumble while implementing the idea. So, given a fertile environment, I contend that we become innovators and tinkerers within our realm. I further contend we can become innovators in wider circle of influence (beyond ourselves) if we desire to do so. The path, then, cannot be so liberally littered by our personal insights as much as getting to the gist of all concerned. Moreover, we need a clarity of purpose.
Ideas become reality in instances where one stands upon the shoulders of giants.
–REFERENCES and READINGS
Specific cancer citation– : Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules Nature Medicine 17, 1685–1691 (2011) doi:10.1038/nm.2554 (the lead author(s) for the work–Hisataka Kobayashi)
READINGS LIST (in no particular order)
Costa, Liliana, Maria Amparo F Faustino, Maria Graça P M S Neves, Angela Cunha, and Adelaide Almeida. “Photodynamic Inactivation of Mammalian Viruses and Bacteriophages.” Viruses 4, no. 7 (July 2012): 1034–74. doi:10.3390/v4071034.
Goodrich, R P, N R Yerram, B H Tay-Goodrich, P Forster, M S Platz, C Kasturi, S C Park, N J Aebischer, S Rai, and L Kulaga. “Selective Inactivation of Viruses in the Presence of Human Platelets: UV Sensitization with Psoralen Derivatives.” Proceedings of the National Academy of Sciences of the United States of America 91, no. 12 (June 07, 1994): 5552–6. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=44034&tool=pmcentrez&rendertype=abstract.
Kiesslich, Tobias, Anita Gollmer, Tim Maisch, Mark Berneburg, and Kristjan Plaetzer. “A Comprehensive Tutorial on in Vitro Characterization of New Photosensitizers for Photodynamic Antitumor Therapy and Photodynamic Inactivation of Microorganisms.” BioMed Research International 2013 (January 2013): 840417. doi:10.1155/2013/840417.
O’Brien, J M, D K Gaffney, T P Wang, and F Sieber. “Merocyanine 540-Sensitized Photoinactivation of Enveloped Viruses in Blood Products: Site and Mechanism of Phototoxicity.” Blood 80, no. 1 (July 01, 1992): 277–85. http://www.ncbi.nlm.nih.gov/pubmed/1319237.
Novo, E, and J Esparza. “Tetracycline-Mediated Photodynamic Inactivation of Animal Viruses.” The Journal of General Virology 45, no. 2 (November 1979): 323–9. http://www.ncbi.nlm.nih.gov/pubmed/120411.
Simonet, Julien, and Christophe Gantzer. “Inactivation of Poliovirus 1 and F-Specific RNA Phages and Degradation of Their Genomes by UV Irradiation at 254 Nanometers.” Applied and Environmental Microbiology 72, no. 12 (December 2006): 7671–7. doi:10.1128/AEM.01106-06.
Vigant, Frederic, Jihye Lee, Axel Hollmann, Lukas B Tanner, Zeynep Akyol Ataman, Tatyana Yun, Guanghou Shui, et al. “A Mechanistic Paradigm for Broad-Spectrum Antivirals That Target Virus-Cell Fusion.” PLoS Pathogens 9, no. 4 (April 2013): e1003297. doi:10.1371/journal.ppat.1003297.